Iovance Biotherapeutics IOVA
NASDAQ IOVA
$14.44 +3.45 (+31.35%)
As of: Sep 29, 2026 · 3:59 PM EDT

Iovance Biotherapeutics (IOVA) Accumulated Expenses (2013 - 2026)

Updated

Iovance Biotherapeutics (IOVA) posted Accumulated Expenses of $77.96 million for Q2 2026, down 12.5% from $89.08 million a year earlier and down 11.5% from the prior quarter.

Analysis

Iovance Biotherapeutics (IOVA) Accumulated Expenses (2013 - 2026) Analysis & Trends

At the end of FY2025, Iovance Biotherapeutics' Accumulated Expenses came in at $111.16 million, up 35.7% from FY2024.

  • Annual Accumulated Expenses has increased for three consecutive years, with a five-year compound annual growth rate of 25.9% (FY2020 to FY2025).
  • In prior years, Iovance Biotherapeutics' Accumulated Expenses was $81.94 million in FY2024 (+18.1%), $69.41 million in FY2023 (+32.7%), $52.3 million in FY2022 (-7.9%) and $56.77 million in FY2021 (+61.8%).
  • The Q2 2026 figure stands as the lowest quarterly Accumulated Expenses since Q1 2024.
  • On a year-over-year basis, Accumulated Expenses increased in four of the last five quarters, with growth averaging 25.5%.
  • The strongest year-over-year quarter for Accumulated Expenses in the past five years was Q1 2025, with growth of 82.4%; the weakest was Q2 2026, with a decline of 12.5%.
  • According to Business Quant data, Accumulated Expenses for the three prior quarters was $88.07 million (Q1 2026), $111.16 million (Q4 2025) and $87.27 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Iovance Biotherapeutics 4.98 Bn 3.77 Bn 55.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 77.96 Mn
Mar 31, 2026 88.07 Mn
Dec 31, 2025 111.16 Mn
Sep 30, 2025 87.27 Mn
Jun 30, 2025 89.08 Mn
Mar 31, 2025 84.71 Mn
Dec 31, 2024 81.94 Mn
Mar 31, 2024 46.44 Mn
Dec 31, 2023 69.41 Mn
Sep 30, 2023 61.21 Mn
Jun 30, 2023 46.62 Mn
Mar 31, 2023 43.09 Mn
Dec 31, 2022 52.30 Mn
Sep 30, 2022 47.82 Mn
Jun 30, 2022 37.70 Mn
Mar 31, 2022 48.91 Mn
Dec 31, 2021 56.77 Mn
Sep 30, 2021 45.97 Mn
Jun 30, 2021 34.19 Mn
Mar 31, 2021 35.77 Mn
API Access

Iovance Biotherapeutics Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=IOVA&period=max&api_key=YOUR_API_KEY